The DOI matches its Crossref record; 159 of the 162 references it cites were found in a registry or an index.
The iron metabolism of neoplastic cells: alterations that facilitate proliferation?
Abstract
For many years it has been known that neoplastic cells express high levels of the transferrin receptor 1 (TfR1) and internalize iron (Fe) from transferrin (Tf) at a tremendous rate. Considering the high requirement of neoplastic cells for Fe, understanding its metabolism is vital in terms of devising potential new therapies. Apart from TfR1, a number of molecules have been identified that may have roles in Fe metabolism and cellular proliferation. These molecules include transferrin (Tf), the oestrogen-inducible transferrin receptor-like protein, transferrin receptor 2 (TfR2), melanotransferrin (MTf), ceruloplasmin, and ferritin. In the present review these latter molecules are discussed in terms of their potential functions in tumour cell Fe metabolism and proliferation. Further studies are essential to determine the specific roles of these proteins in the pathogenesis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The malignant cancer phenotype is often found in association with a deregulated iron homeostasis, particularly the expression of iron-regulated genes that fuel their higher metabolic iron demands needed for division, growth, and survival [10].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [10]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., VARMUS, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,261
Nitric oxide: A cytotoxic activated macrophage effector molecule
Hibbs, J. B., Taintor, R. R., Vavrin, Z., & Rachlin, E. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80015-9 · Cited by 2,034
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Schwab, M., Alitalo, K. K., Klempnauer, K.-H., VARMUS, H. E., Bishop, J. M., Gilbert, F., Brodeur, G. M., Goldstein, M. N., & Trent, J. M. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,405
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Iron Transport and Storage Proteins
Aisen, P., & Listowsky, I. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002041 · Cited by 1,179
Thelander, L., & Reichard, P. A. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001025 · Cited by 1,160
Research works printed but not linked: 2
- Frantz CN, Iyer J, Frick KK, Eskenazi AE, Derg PE. Iron and N-myc expression in neuroblastoma. Proceedings of the Neuroblastoma Research Meeting, Philadelphia, USA; 1993.
- Frantz CN, Eskenazi AE, Overman D. Iron chelation cancer therapy for neuroblastoma. Proceedings of the International Conference on Bioiron, Asheville, North Carolina, USA; 1995. p. 195.
Cited by
Sorted by citations
Items 101–200 of 215
Ranjbary, A. G., Mehrzad, J., Dehghani, H., Abdollahi, A., & Hosseinkhani, S. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01749-9 · Cited by 29
Reverse Chemical Proteomics Identifies an Unanticipated Human Target of the Antimalarial Artesunate
Gotsbacher, M. P., Cho, S. M., Kim, N. H., Liu, F., Kwon, H. J., & Karuso, P. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01004 · Cited by 28
Galectin-3 Guides Intracellular Trafficking of Some Human Serotransferrin Glycoforms
Carlsson, M. C., Bengtson, P., Cucak, H., & Leffler, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.487793 · Cited by 27
Regulation of iron homeostasis by microRNAs
Castoldi, M., & Muckenthaler, M. U. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1031-4 · Cited by 30
“It was recognized some time ago that Tfr1 expression is increased in neoplastic cells to satisfy their increased iron requirements for cellular proliferation [45, 46].”
BackgroundThe Eltrombopag antitumor effect on hepatocellular carcinoma
Kurokawa, T., Murata, S., Zheng, Y., IWASAKI, K., Kohno, K., Fukunaga, K., & Ohkohchi, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3180 · Cited by 29
“Cellular Fe depletion typically results in G1/S arrest (36,37), which indicates that this metal is essential for cell cycle progression as well as cell growth and division (38,39).”
BackgroundExploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents
Merlot, A. M., Kalinowski, D. S., Kovačević, Ž., Jansson, P. J., Sahni, S., Huang, M., Lane, D. J. R., Lok, H. C., & Richardson, D. R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170705120809 · Cited by 29
Rambow, F., Malek, O., Geffrotin, C., Leplat, J. J. J. J., Bouet, S., Piton, G., Hugot, K., Bevilacqua, C., Horák, V., & Vincent-Naulleau, S. S. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00442.x · Cited by 26
“These dual genes comprise CAV1 (Williams and Lisanti, 2005) which can act as tumour suppressor or oncogene, CP (Kwok and Richardson, 2002) which plays a role in anti-tumour defense or metastasis development and clusterin (CLU).”
BackgroundBrain slice invasion model reveals genes differentially regulated in glioma invasion
Holtkamp, N., Afanasieva, A., Elstner, A., van Landeghem, F. K. H., Könneker, M., Kuhn, S. A., Kettenmann, H., & von Deimling, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.253 · Cited by 25
Nabi, N., Singh, S. K., & Saffeullah, P. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113798 · Cited by 25
Dharmasivam, M., Kaya, B., Wijesinghe, T. P., Richardson, V., Harmer, J. R., Gonzálvez, M. A., Lewis, W., Azad, M. G., Bernhardt, P. V., & Richardson, D. R. (2023) · Chemical Science · doi:10.1039/d3sc05723b · Cited by 23
Lodhi, M. S., Khan, M. T., Aftab, S., Samra, Z. Q., Wang, H., & Wei, D. Q. (2021) · Cancer Nanotechnology · doi:10.1186/s12645-021-00098-4 · Cited by 23
Zhou, H., Chen, J., Fan, M., Cai, H., Dong, Y., Qiu, Y., Zhuang, Q., Lei, Z., Li, M., Ding, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02562-4 · Cited by 23
“Cancer cells have higher metabolic iron demand to sustain their division, growth, and survival [58].”
BackgroundDeu, E., Chen, I. T., Lauterwasser, E. M. W., Valderramos, J., Li, H., Edgington‐Mitchell, L. E., Renslo, A. R., & Bogyo, M. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312782110 · Cited by 23
“Parasite lysates were diluted 100-fold in acetate buffer containing different concentrations of compound and 10 μM (PR)2Rho, a fluorogenic substrate that is specific for DPAP1 in parasite lysates (2).”
BackgroundMethodDertz, E. A., & Raymond, K. N. (2003) · Elsevier eBooks · doi:10.1016/b0-08-043748-6/08175-5 · Cited by 23
Can we use high precision metal isotope analysis to improve our understanding of cancer?
Larner, F. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9201-5 · Cited by 21
“It has become increasingly clear in the past decade that there are changes in the way trace metals are processed in a range of widespread conditions including neurological disease [6], diabetes [7] and cancer [8], which have particular relevance in our aging population.”
BackgroundYadav, V. K., Choudhary, N., Gacem, A., Verma, R. K., Hasan, M. A., Imam, M. T., Almalki, Z. S., Yadav, K. K., Park, H.-K., Ghosh, T., et al. (2023) · Redox Report · doi:10.1080/13510002.2023.2269331 · Cited by 22
“From the investigations, it has been revealed that the neoplastic cells have increased iron concentration than the non-cancerous cells [180].”
BackgroundHaemochromatosis gene (HFE) mutations in viral-associated neoplasia: Linkage to cervical cancer
Cardoso, C. S. D. F. L. P., Araújo, H. C., Cruz, E., Afonso, A., Mascarenhas, C., Almeida, S., Moutinho, J., Lopes, C., & Medeiros, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.174 · Cited by 20
Regulation of p27Kip1 by intracellular iron levels
Wang, G. G., Miskimins, R., & Miskimins, W. K. (2003) · BioMetals · doi:10.1023/a:1024417309370 · Cited by 20
Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells
Juang, H. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000044395.59739.1f · Cited by 20
“The deregulation of iron metabolism, iron uptake mechanisms and iron feedback loop may induce neoplasia or facilitate cell proliferation of tumor cell [18].”
BackgroundFerroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
Pogribny, I. P. (2010) · Breast Cancer Research · doi:10.1186/bcr2641 · Cited by 19
“Iron homeostasis in normal cells is accurately balanced and tightly regulated by a coordinated functioning of several systems that are responsible for the uptake, intracellular storage, and removal of iron from cells [1]; in cancer cells, however, this balance is frequently and consistently compromised [2,3].”
BackgroundMarkers of iron metabolism in retired racing Greyhounds with and without osteosarcoma
T., J., Marín, L. M., Iazbik, M. C., Zaldívar‐López, S., Borghese, H., & Couto, C. G. (2013) · Veterinary Clinical Pathology · doi:10.1111/vcp.12066 · Cited by 18
“However, iron can also favor carcinogenesis, as neoplastic cells express high levels of transferrin receptors and internalize large amounts of iron from transferrin molecules.(7) In fact, one of the main reasons for the use of iron chelators in antitumor therapy is that rising blood iron levels appear to correlate with”
BackgroundSun, J., Wang, J., Wang, S., Yuan, D., Li, Z., Yi, B., Hou, Q., Mao, Y., & Liu, W. (2014) · Virology Journal · doi:10.1186/s12985-014-0210-3 · Cited by 19
“TfR is central to the uptake of iron-loaded transferrin [42] which is post-transcriptionally regulated via iron-responsive elements present in its 3′UTR [43].”
BackgroundZhang, S. Q., Xu, H. B., Zhang, S. J., & Li, X. Y. (2020) · Medical Science Monitor · doi:10.12659/msm.923624 · Cited by 18
Corcé, V., Morin-Picardat, E., Guihéneuf, S., Renault, É., Renaud, S., Cannie, I., Tripier, R., Lima, L. M. P., Julienne, K., Gouin, S. G., et al. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300324c · Cited by 18
Mannello, F., Tonti, G. A., Simone, P., Ligi, D., & Medda, V. (2010) · PubMed Central · Cited by 17
Dominici, S., Pieri, L., Comporti, M., & Alfonso Pompella, C. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-7 · Cited by 16
“It is well established that the generally higher iron uptake by cancer cells is often the result of a higher number of transferrin receptors [8].”
BackgroundNiméus, E., Malmström, J. A., Johnsson, A., Marko‐Varga, G., & Fernö, M. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.09.019 · Cited by 16
Wijesinghe, T. P., Kaya, B., Gonzálvez, M. A., Harmer, J. R., Azad, M. G., Bernhardt, P. V., Dharmasivam, M., & Richardson, D. R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01612 · Cited by 15
β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents
Sharma, V., Chaudhry, A., Chashoo, G., Arora, R., Arora, S., Saxena, A. K., & Ishar, M. P. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.049 · Cited by 15
Szemraj, M., Oszajca, K., Szemraj, J., & Jurowski, P. (2017) · Medical Science Monitor · doi:10.12659/msm.902366 · Cited by 15
“Proteins involved in the metabolism of iron ions are typically synthesized by hepatocytes, but their levels vary in different diseases [26].”
BackgroundBae, D.-H., Lane, D. J. R., Siafakas, A. R., Šuťák, R., Paluncic, J., Huang, M., Jansson, P. J., Rahmanto, Y. S., & Richardson, D. R. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165844 · Cited by 15
Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
Yang, M., Li, M., Lyu, Z., & Yang, Z. (2023) · Cancer Management and Research · doi:10.2147/cmar.s406150 · Cited by 15
“Depletion of iron-responsive element binding protein 2, which encodes the key regulator of iron metabolism, dramatically suppresses induced ferroptosis.(68) In addition, a critical role for the Ras/Raf/MEK signaling pathway has been revealed in ferroptosis vulnerability.”
BackgroundSamara, A., Shapira, S., Lubin, I., Shpilberg, O., Avigad, S., Granot, G., & Raanani, P. (2021) · British Journal of Haematology · doi:10.1111/bjh.17284 · Cited by 14
Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis
Zhang, Y., Feng, X., Zhang, J., Chen, M., Huang, E. C., & Chen, X. (2019) · Oncogene · doi:10.1038/s41388-019-0876-5 · Cited by 17
Tye, S. L., Gilg, A. G., Tolliver, L. B., Wheeler, W. G., Toole, B. P., & Maria, B. L. (2008) · Journal of Child Neurology · doi:10.1177/0883073808321066 · Cited by 15
“When the cell is depleted of iron, G1 arrest occurs.(41,42) Therefore, one way of reducing proliferation of cancer cells is to chelate available iron.”
BackgroundAli, A. H., Hachem, M., & Ahmmed, M. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30946 · Cited by 15
“Targeting cancer cells with LDL-DHA nanoparticles creates a phenomenon often referred to as the “ typical storm ” in which PUFA, substantially effective substrates toward lipids peroxidation [89], are introduced into the cellular environment with irregular iron and redox metabolisms [90].”
BackgroundLim, M. C., Kim, J., Kim, T. H., Park, S., Kong, S., Yoon, J.-H., Kang, S., Seo, S., & Park, S. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.6.993 · Cited by 13
Alonso-García, F. J., Blanco‐González, E., & Montes‐Bayón, M. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.020 · Cited by 13
Roperto, S., Borzacchiello, G., Brun, R., Costanzo, F. S., Faniello, M. C., Raso, C. A., Rosati, A., Russo, V., Leonardi, L., Saracino, D., et al. (2009) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2009.05.009 · Cited by 13
“, 1994; Torti and Torti, 2002) and this is believed to be a marker of malignancy (Kwok and Richardson, 2002; Orino and Watanabe, 2008).”
BackgroundOtto‐Ślusarczyk, D., Mielczarek‐Puta, M., & Graboń, W. (2021) · Pharmaceuticals · doi:10.3390/ph14100976 · Cited by 12
Probing Transferrin Receptor Overexpression in Gastric Cancer Mice Models
Lodhi, M. S., Khan, M. T., Bukhari, S. M. H., Sabir, S. H., Samra, Z. Q., Butt, H., & Akram, M. S. (2021) · ACS Omega · doi:10.1021/acsomega.1c04382 · Cited by 12
Iron Compounds as Anticancer Agents
Vessières, A. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016452-00062 · Cited by 12
Antibody-mediated targeting of the transferrin receptor in cancer cells
Lurı́a-Pérez, R., Helguera, G. F., & Rodríguez, J. A. (2016) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.1016/j.bmhime.2017.11.035 · Cited by 12
Phototherapy and malignancy: Possible enhancement by iron administration and hyperbaric oxygen
Al-Waili, N. S. D., & Butler, G. J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.12.052 · Cited by 12
“Hemin can passively diffuse into the cells [10].”
BackgroundInfluentialConnor, C. W. A. J. (2014) · Translational Oncogenomics · doi:10.4137/tog.s19064 · Cited by 11
Salehi, S., Saljooghi, A. S., & Izadyar, M. (2016) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.05.010 · Cited by 10
New polyazamacrocyclic 3-hydroxy-4-pyridinone based ligands for iron depletion antitumor activity
Liu, X., Dong, X., He, C., Zhang, X., Xiang, G., & Ma, X. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103574 · Cited by 11
The Crosstalk between Micro RNA and Iron Homeostasis
Li, Z. S. Y. (2013) · International Journal of Genomic Medicine · doi:10.4172/2332-0672.1000112 · Cited by 10
“It was recognized that TfR1 expression is increased in neoplastic cells to satisfy their increased iron requirements for cellular proliferation [78,79].”
BackgroundMarques, O., Canadas‐Sousa, A., Faria, F., Oliveira, E., Amorim, I., Seixas, F., Gama, A., Lobo‐da‐Cunha, A., da Silva, B. M., Porto, G., et al. (2017) · Biotechnic & Histochemistry · doi:10.1080/10520295.2017.1369160 · Cited by 11
“It appears that iron may affect the development, behavior and progression of cancer (Kwok and Richardson 2002, Huang 2008).”
BackgroundWoei-A-Jin, F. J. S. H., Zheng, S. Z., Kiliçsoy, I., Hudig, F., Luelmo, S. A. C., Kroep, J. R., Lamb, H. J., & Osanto, S. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0222 · Cited by 9
“Importantly, as cancer cells have high iron requirements to support their growth [61, 62], iron administration may negatively impact patient outcome.”
BackgroundIron overload of human colon adenocarcinoma cells studied by synchrotron-based X-ray techniques
Mihucz, V. G., Meirer, F., Polgári, Z., Réti, A., Pepponi, G., Ingerle, D., Szoboszlai, N., & Streli, C. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-015-1331-x · Cited by 8
Kaumeyer, B. A., Fidai, S. S., Thakral, B., Wang, S. A., Arber, D. A., Cheng, J. X., Gurbuxani, S. K., & Venkataraman, G. (2022) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqac034 · Cited by 8
Laube, F., & Glanz, D. (2017) · Anticancer Research · doi:10.21873/anticanres.11654 · Cited by 8
Nagata, T., Takahashi, Y., Ishii, Y., Asai, S., Sugahara, M., Nishida, Y., Murata, A., Yamamori, S., Ogawa, Y., Nakamura, T., et al. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.05.009 · Cited by 8
“The increased expression of genes regulating cell growth (5 genes: IGF2, IGFBP6, EMP1, TFRC, ABL1) in this MRTK tumor sample also suggests alterations of signaling for cell growth in this MRTK tumor [38–41] (Table 2).”
BackgroundBreast tumor metastasis: analysis via proteomic profiling
Steve Goodison, B., & Urquidi, V. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.3.457 · Cited by 8
Can the iron content of culture media impact on the leishmanicidal effect of artemisinin?
Dighal, A., Sarkar, S. D., Gille, L., & Chatterjee, M. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1939325 · Cited by 7
Okonda, J. J., Angeyo, H. K., Dehayem-Kamadjeu, A., & Rogena, A. E. (2023) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2023.106671 · Cited by 7
Uçmak, Z. G., Koenhemsi̇, L., Ateş, F., Tarhan, D., GÜRGEN, H. Ö., Yıldırım, F., Uçmak, M., Kırşan, İ., Ercan, M., & Or, M. E. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127246 · Cited by 7
Dihydroartemisinin induces caspase-8-dependent apoptosis in murine GT1-7 hypothalamic neurons
Raghavamenon, A. C., Muyiwa, A. F., Davis, L. K., & Uppu, R. M. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.552534 · Cited by 7
Iron metabolism in breast cancer: knowledge and future
Durigova, A., Jacot, W., Pouderoux, S., Roques, S., Montels, F., & Lamy, P. (2012) · Annales de biologie clinique · doi:10.1684/abc.2012.0700 · Cited by 7
Conti, G., Pitea, M., Ossanna, R., Opri, R., Tisci, G., Falvo, E., Innamorati, G., Ghanem, E., Sbarbati, A., Ceci, P., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111622 · Cited by 7
“The tumorigenicity associated with the expression of TfR is not only due to the greater demand for iron, an essential cofactor for the functionality of many enzymes including those involved in the synthesis of nucleic acids feeding cellular proliferation, but also to other factors [24,25].”
BackgroundParodi, S., Perfumo, C., Garaventa, A., Inga, A., Mazzocco, K., Defferrari, R., Tonini, G. P., Fronza, G., & Haupt, R. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22477 · Cited by 6
“Iron metabolism in NB is altered compared to other cell types and cells from NB have been reported to contain iron-rich ferritin and to secrete it [28].”
BackgroundGong, Y., Chen, R., Zhang, X., Zou, Z., & Chen, X. H. (2017) · PubMed · doi:10.3967/bes2017.065 · Cited by 6
“In addition, the components of the differential white blood cell count (WBC-DC), systematic inflammatory and metabolic markers, such as LDH, β2-microglobulin (β2MG), and iron, in peripheral blood are useful inexpensive parameters to categorize the prognoses of malignant diseases including solid and hematological malig…”
BackgroundEngineering Quantum Dot (Cadmium Sulfide) on Antibodies for Fluoroimmunoassays
Lodhi, M. S., & Samra, Z. Q. (2020) · Journal of Nanomaterials · doi:10.1155/2020/4707123 · Cited by 6
“That can be justified due to high iron demand of abruptly growing cells for their DNA manipulation and energy cycles involved in cell cycle progression [23, 24].”
BackgroundSanagoo, A., Kiani, F., Naz, M. S. G., Sayehmiri, F., Koohi, F., Jouybari, L. M., & Dousti, M. (2020) · Europe PMC (PubMed Central) · doi:10.22088/cjim.11.1.1 · Cited by 6
“It fundamentally contributes in the arrangement of cellular growth and differentiation (46).”
BackgroundIron metabolism in prostate cancer
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00011-4 · Cited by 5
Jochims, F., Strohm, R., von Montfort, C., Wenzel, C.-K., Klahm, N. P., Kondadi, A. K., Stahl, W., Reichert, A. S., & Brenneisen, P. (2023) · Biomedicines · doi:10.3390/biomedicines11092393 · Cited by 5
Pandher, R., Xue, C., Gamble, L. D., Milazzo, G., Giacomo, S. D., Murray, J. E., Cheung, L., Ferrucci, F., Palombo, M., Purgato, S., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420011122 · Cited by 5
“Despite iron being an essential element required for normal cell proliferation and metabolism, altered iron metabolism has been implicated in tumor initiation and growth ( 38 , 39 ).”
Ascorbate and Tumor Cell Iron Metabolism: The Evolving Story and Its Link to Pathology
Bae, D.-H., Azad, M. G., Kalinowski, D. S., Lane, D. J. R., Jansson, P. J., & Richardson, D. R. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7903 · Cited by 6
“Iron plays a fundamental role in cellular survival and proliferation (114, 128).”
Cancer and mosquitoes – An unsuspected close connection
Arnal, A., Roche, B., Gouagna, L., Dujon, A. M., Újvári, B., Corbel, V., Remoué, F., Poinsignon, A., Pompon, J., Giraudeau, M., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140631 · Cited by 5
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells
Menghini, S., Vizovišek, M., Enders, J., & Schuerle, S. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00313-3 · Cited by 6
Ford, S., Bedford, M., Pang, W.-Y., WOOD, A. G., Iqbal, T. H., Tselepis, C., & Tucker, O. (2014) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588414x13946184900282 · Cited by 6
“These associations are not entirely surprising as iron is essential for a number of key cellular processes including synthesis of deoxyribonucleic acid, adenosine triphosphate generation and cell cycle progression, all of which are increased in cancer.(10) With this in mind, there is now evidence suggesting that iron…”
BackgroundIron uptake by melanoma cells from the soluble form of the transferrin homologue, melanotransferrin
Food, M. R., & Richardson, D. R. (2002) · Redox Report · doi:10.1179/135100002125000794 · Cited by 5
Zhang, Y., Song, D., Han, X., Liu, H., Wang, Y., Wang, X., & Dou, C. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2441705 · Cited by 5
“Researchers initially hypothesized that the overexpression of CD228 in melanoma cells satisfies the iron requirements for tumor proliferation [12,13].”
Kim, E. T., & Park, D.-G. (2020) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.20020 · Cited by 4
“Cancer cells contain substantial free iron, resulting from their higher rate of iron uptake via transferrin receptors compared with normal cells [5].”
BackgroundMustafa, R. M. A., & Husain, N. E. (2017) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v12i3.915 · Cited by 4
“Being highly proliferative, tumour cells need more iron and they usually show high intracellular iron concentration [13, 14].”
BackgroundRenaud, S., Corcé, V., Cannie, I., Ropert, M., Lepage, S., Loréal, O., Deniaud, D., & Gaboriau, F. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.001 · Cited by 4
“the iron importing proteins and a decrease in the expression of iron exporting proteins [4-6].”
BackgroundEslaminejad, T., Pourshojaei, Y., Naghizadeh, M., Eslami, H., Daneshpajouh, M., & Hassanzadeh, A. (2022) · Journal of the Serbian Chemical Society · doi:10.2298/jsc210630016e · Cited by 3
Chikazawa, S., KITAHARA, Y., Ando, E., Hori, Y., Hoshi, F., Kanai, K., Ito, N., & Higuchi, S. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0319 · Cited by 3
“Cancer cells have an increased capacity to synthesize heme and increased requirements for iron in order to sustain rapid cell proliferation, and this is the basis for photodynamic therapies for cancer [9, 11].”
BackgroundDharmasivam, M., Faiz, S., Kaya, B., Wijesinghe, T. P., Süleymanoğlu, M., Azad, M. G., Richardson, V., Zahoor, A. F., Kalinowski, D. S., Lewis, W., et al. (2026) · Chemical Science · doi:10.1039/d5sc06084b · Cited by 3
Nutrigenomics in the management and prevention of cancer
Lim, C. J. C., Lim, P. P., Pizarro, R. R. M., Segocio, H. G. B., & Ratta, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824412-8.00002-3 · Cited by 3
Comparative Analysis of Iron Metabolism and Its Adjustment Changes at Cancer Patients in Childhood
Yavuz, G., Ünal, E., Taçyıldız, N., Köse, S. K., Gökçe, H., Gördü, Z., Pekpak, E., Aksoy, B. A., İlarslan, N. E. Ç., Günay, F., et al. (2017) · Iranian Journal of Pediatrics · doi:10.5812/ijp.10092 · Cited by 2
“These cancers include lung cancer, breast cancer, prostate cancer, colorectal cancer, hepatocellular cancer, pancreatic cancer, hematological cancers, renal cell carcinoma and melanoma (9).”
BackgroundNeisi, E., & Hasanvandi, S. (2023) · Preprints.org · doi:10.20944/preprints202308.2171.v1 · Cited by 1
A role for deferasirox as an anti-neoplastic and chemosensitising agent in gastrointestinal cancer
Bedford, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Exogenously Induced Endogenous Photosensitizers
Heuck, G., & Lange, N. (2011) · Springer eBooks · doi:10.1007/978-90-481-3872-2_8
The role of haem transport and iron chelation in oesophageal cancer
Ford, S. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Leporowska, E. (2012) · Zeszyty Naukowe WCO Letters in Oncology Science · doi:10.1016/s1734-0489(12)70007-x
Integrative Physician's Perspective, With a Special Consideration of St John’s Wort
Block, K. I. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735405279877
Firman, J. W. (2015) · University of Liverpool · doi:10.17638/02012740
Evans, H. L. (2014) · Journal of Leukemia · doi:10.4172/2329-6917.1000141
“One caveat in solely relying on CD71 as an erythroid marker is that it can also be expressed by some other highly proliferative neoplasms such as diffuse large B-cell lymphoma [23-25], in particular, by flow cytometry phenotyping.”
BackgroundDavis, C. F., & Dorak, M. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6752-7_17
“, 1988; de Sousa, 1989; Brock and Mulero, 2000; Walker and Walker, 2000; Porto and De Sousa, 2007) – Iron as an essential nutrient for proliferating neoplastic cells (Bergeron, 1986; Cazzola et al., 1990; Sussman, 1992; Kwok and Richardson, 2002; Butterworth, 2006) – Animal experiments showing pro-carcinogenic effect…”
BackgroundAre Calcium Channels More Important Than Calcium Influx for Cell Proliferation?
Borowiec, A., Bidaux, G., & Capiod, T. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_4
The cellular and functional role of melanotransferrin in melanomas
Tian, M. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0069952
Zeng, Q.-P. (2015) · Springer briefs in molecular science · doi:10.1007/978-3-662-47688-8_3
Leite, L. R. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/v3x7-ys11
Armani, A. L. C., Prado, S. B. R., & Malachias, V. T. (2014) · CRC Press eBooks · doi:10.1201/b16653-31
Jia, F. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3fj29n0d
Guo, Y., Song, C., Zhang, L., Han, Z., & Zhu, L. (2022) · Research Square · doi:10.21203/rs.3.rs-2317277/v1
Metadata
- Authors
- Kwok, J. C., & Richardson, D. R.
- Affiliations
- The Heart Research Institute (AU)
- Corresponding author
- Richardson, Des R.
- ORCID
- Richardson, Des R.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 42
- Issue
- 1
- Pages
- 65-78
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2049332203
- Cited by
- 215
- References
- 162
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 14 · 2023: 15 · 2022: 5 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 6 · 2017: 13 · 2016: 9 · 2015: 13 · 2014: 10 · 2013: 18 · 2012: 9
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Oncology/Hematology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- iron metabolism, neoplastic cells, transferrin receptor 1, transferrin receptor 2, transferrin, melanotransferrin, ceruloplasmin, ferritin, tumor cell proliferation, carcinogenesis, iron transport
- MeSH terms
- Animals, Antigens, Neoplasm, Biological Transport, Cell Division, Ceruloplasmin, Endocytosis, Estrogens, Ferritins, Humans, Iron, Neoplasm Proteins, Neoplasms, Receptors, Transferrin, Transferrin, Nonheme Iron Proteins, Melanoma-Specific Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review